Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vom Dorp

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Der Urologe. Ausg. A|September 20, 2011
[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Der Urologe. Ausg. A|August 2, 2007
[Founding a "Lymph Node Metastasis" Study Group at the West German Tumor Center (WTZE)]M Schenck, F vom Dorp, C Boergermann, et al.
Der Urologe. Ausg. A|August 2, 2007
[Identification of the molecular bases of metastasis for the development of new therapy strategies of metastatic prostate carcinoma]M Schenck, C Boergermann, F vom Dorp, et al.
Der Urologe. Ausg. A|August 22, 2009
[The value of urinary cytology in the diagnosis of high grade urothelial tumors]C Niedworok, V Rembrink, O W Hakenberg, et al.
Der Urologe. Ausg. A|June 29, 2007
[Proapoptotic antibodies as new therapeutic agents for tumor treatment]M Schenck, C Börgermann, F vom Dorp, et al.
Der Urologe. Ausg. A|June 23, 2006
[Noninvasive and invasive bladder cancer: diagnostics and treatment]P J Goebell, F Vom Dorp, C Rödel, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Der Urologe. Ausg. A|September 20, 2011
[How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases]M Schenck, W Michels-Oswald, S Tschirdewahn, et al.
Der Urologe. Ausg. A|August 2, 2007
[Founding a "Lymph Node Metastasis" Study Group at the West German Tumor Center (WTZE)]M Schenck, F vom Dorp, C Boergermann, et al.
Der Urologe. Ausg. A|August 2, 2007
[Identification of the molecular bases of metastasis for the development of new therapy strategies of metastatic prostate carcinoma]M Schenck, C Boergermann, F vom Dorp, et al.
Der Urologe. Ausg. A|August 22, 2009
[The value of urinary cytology in the diagnosis of high grade urothelial tumors]C Niedworok, V Rembrink, O W Hakenberg, et al.
Der Urologe. Ausg. A|June 29, 2007
[Proapoptotic antibodies as new therapeutic agents for tumor treatment]M Schenck, C Börgermann, F vom Dorp, et al.
Der Urologe. Ausg. A|June 23, 2006
[Noninvasive and invasive bladder cancer: diagnostics and treatment]P J Goebell, F Vom Dorp, C Rödel, et al.
World Journal of Urology|February 21, 2020
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
World Journal of Urology|February 16, 2015
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrenceA Karl, A Buchner, C Tympner, et al.
Pageof 6